Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
ABSSSI, accretion, affirmative, affirmed, affirming, Allegan, bacterial, Black, Bylaw, cast, clean, covenant, dalbavancin, dealing, delafloxacin, disbursed, disregarding, doxycycline, escrow, explanatory, futility, hereunder, incorrect, mandatorily, mezzanine, motion, neurological, oritavancin, OTCQB, overview, pause, petition, petitioned, pre, quarantine, redirect, reprioritization, rounded, spine, tedizolid, uphold, vacate, vancomycin
Removed:
add, annum, assumed, biosimilar, charitable, commitment, consecutive, consummation, dose, establishment, failed, frequency, MAA, modifying, noncancelable, origin, preserve, ratio, receiving, recommend, reconsider, regain, remained, salary, serve, shorter, Simplifying, Stifel, strain, sublease, surveillance, therapy, threshold, Trump, Wuhan
Filing tables
Filing exhibits
Related press release
HSTO similar filings
Filing view
External links
Exhibit 21.1
SUBSIDIARIES OF HISTOGEN INC.
1.
Histogen Therapeutics, Inc., formerly Histogen Inc., incorporated in Delaware on June 25, 2007.
2.
Centro de Investigación de Medicina Regenerativa, S.A. de C.V., incorporated in Mexico on October 9, 2014.